Australia's PBS Rejects Coverage Of Janssen Schizoprenia Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's drug-coverage agency has declined to subsidize U.S.-based Janssen's Invega Sustenna (paliperidone), apparently in response to budget pressures